Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17619
Country/Region: Rwanda
Year: 2018
Main Partner: Emory University
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $2,210,561 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $3,000
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $58,673
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $734,574
Sexual Prevention: Other Sexual Prevention (HVOP) $1,156,801
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $257,513
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 10,931
HTS_SELF 15-19, Female, Directly-Assisted 2019 547
HTS_SELF 15-19, Female, Unassisted 2019 547
HTS_SELF 15-19, Male, Directly-Assisted 2019 547
HTS_SELF 15-19, Male, Unassisted 2019 547
HTS_SELF 20-24, Female, Directly-Assisted 2019 547
HTS_SELF 20-24, Female, Unassisted 2019 867
HTS_SELF 20-24, Male, Directly-Assisted 2019 342
HTS_SELF 20-24, Male, Unassisted 2019 430
HTS_SELF 25-29, Female, Directly-Assisted 2019 109
HTS_SELF 25-29, Female, Unassisted 2019 547
HTS_SELF 25-29, Male, Unassisted 2019 547
HTS_SELF 30-34, Female, Directly-Assisted 2019 109
HTS_SELF 30-34, Female, Unassisted 2019 547
HTS_SELF 30-34, Male, Directly-Assisted 2019 109
HTS_SELF 30-34, Male, Unassisted 2019 547
HTS_SELF 35-39, Female, Directly-Assisted 2019 109
HTS_SELF 35-39, Female, Unassisted 2019 547
HTS_SELF 35-39, Male, Directly-Assisted 2019 109
HTS_SELF 35-39, Male, Unassisted 2019 547
HTS_SELF 40-49, Female, Directly-Assisted 2019 547
HTS_SELF 40-49, Female, Unassisted 2019 547
HTS_SELF 40-49, Male, Directly-Assisted 2019 547
HTS_SELF 40-49, Male, Unassisted 2019 547
HTS_SELF 50+, Female, Unassisted 2019 547
HTS_SELF Directly-Assisted 2019 3,621
HTS_SELF FSW, Unassisted 2019 2,187
HTS_SELF MSM, Unassisted 2019 389
HTS_SELF Unassisted 2019 7,310
HTS_TST 25-29, Female, Negative 2019 2,703
HTS_TST 25-29, Female, Negative 2019 666
HTS_TST 25-29, Male, Negative 2019 2,916
HTS_TST 25-29, Male, Negative 2019 933
HTS_TST 25-29, Male, Negative 2019 290
HTS_TST 30-34, Female, Negative 2019 2,602
HTS_TST 30-34, Female, Negative 2019 1,200
HTS_TST 30-34, Male, Negative 2019 2,016
HTS_TST 30-34, Male, Negative 2019 1,068
HTS_TST 30-34, Male, Negative 2019 434
HTS_TST 35-39, Female, Negative 2019 1,960
HTS_TST 35-39, Female, Negative 2019 933
HTS_TST 35-39, Male, Negative 2019 2,066
HTS_TST 35-39, Male, Negative 2019 801
HTS_TST 35-39, Male, Negative 2019 300
HTS_TST 40-49, Female, Negative 2019 2,434
HTS_TST 40-49, Female, Negative 2019 933
HTS_TST 40-49, Male, Negative 2019 2,255
HTS_TST 40-49, Male, Negative 2019 801
HTS_TST 40-49, Male, Negative 2019 60
HTS_TST By Key Population: FSW, Negative 2019 9,227
HTS_TST By Key Population: MSM, Negative 2019 1,401
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 55,801
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 2,765
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 1,626
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 7,838
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 3,291
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 1,352
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 938
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 978
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 527
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 4,530
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 603
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 345
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 234
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 1,440
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 470
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 118
HTS_TST_POS 25-29, Female, Positive 2019 34
HTS_TST_POS 25-29, Male, Positive 2019 109
HTS_TST_POS 25-29, Male, Positive 2019 34
HTS_TST_POS 30-34, Female, Positive 2019 68
HTS_TST_POS 30-34, Female, Positive 2019 20
HTS_TST_POS 30-34, Male, Positive 2019 109
HTS_TST_POS 30-34, Male, Positive 2019 34
HTS_TST_POS 35-39, Female, Positive 2019 118
HTS_TST_POS 35-39, Female, Positive 2019 34
HTS_TST_POS 35-39, Male, Positive 2019 91
HTS_TST_POS 35-39, Male, Positive 2019 26
HTS_TST_POS 40-49, Female, Positive 2019 81
HTS_TST_POS 40-49, Female, Positive 2019 24
HTS_TST_POS 40-49, Male, Positive 2019 56
HTS_TST_POS 40-49, Male, Positive 2019 16
HTS_TST_POS By Key Population: FSW, Positive 2019 554
HTS_TST_POS By Key Population: MSM, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 72
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 160
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 108
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 21
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 54
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 16
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 15,598
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 1,440
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 17,038
PP_PREV 25-29, Female 2019 2,855
PP_PREV 25-29, Male 2019 1,476
PP_PREV 30-34, Female 2019 2,855
PP_PREV 30-34, Male 2019 1,476
PP_PREV 35-39, Female 2019 1,476
PP_PREV 35-39, Male 2019 2,950
PP_PREV 40-49, Female 2019 1,476
PP_PREV 40-49, Male 2019 1,476
PP_PREV Age/sex: 15-19 Female 2019 1,476
PP_PREV Age/sex: 15-19 Male 2019 1,476
PP_PREV Age/sex: 20-24 Female 2019 4,425
PP_PREV Age/sex: 20-24 Male 2019 4,426
PP_PREV Age/sex: 50+ Male 2019 1,481
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 29,324
PP_PREV Sum of Age/Sex disaggregates 2019 13,284
PrEP_NEW 25-29, Female 2019 305
PrEP_NEW 30-34, Female 2019 244
PrEP_NEW 35-39, Female 2019 244
PrEP_NEW 40-49, Female 2019 61
PrEP_NEW Female 15-19 2019 61
PrEP_NEW Female 20-24 2019 305
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 1,222
TX_NEW 25-29, Female, Positive 2019 28
TX_NEW 25-29, Male, Positive 2019 23
TX_NEW 30-34, Female, Positive 2019 26
TX_NEW 30-34, Male, Positive 2019 25
TX_NEW 35-39, Female, Positive 2019 26
TX_NEW 35-39, Male, Positive 2019 23
TX_NEW 40-49, Female, Positive 2019 26
TX_NEW 40-49, Male, Positive 2019 23
TX_NEW Breastfeeding status 2019 1
TX_NEW By Age/Sex: 15-19 Female 2019 11
TX_NEW By Age/Sex: 15-19 Male 2019 3
TX_NEW By Age/Sex: 20-24 Female 2019 55
TX_NEW By Age/Sex: 20-24 Male 2019 9
TX_NEW By Age/Sex: 50+ Female 2019 2
TX_NEW By Age/Sex: 50+ Male 2019 1
TX_NEW FSW 2019 93
TX_NEW MSM 2019 11
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 282
TX_NEW Pregnancy status 2019 2
TX_NEW Sum of Age/Sex disaggregates 2019 81
VMMC_CIRC 30-34, Male 2019 360
VMMC_CIRC 35-39, Male 2019 270
VMMC_CIRC 40-49, Male 2019 45
VMMC_CIRC By Age: 10-14 2019 225
VMMC_CIRC By Age: 15-19 2019 1,060
VMMC_CIRC By Age: 20-24 2019 630
VMMC_CIRC By Age: 25-29 2019 410
VMMC_CIRC By circumcision technique: Device-based VMMC 2019 900
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 2,100
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 3,000
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 2,325
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 1,915
Cross Cutting Budget Categories and Known Amounts Total: $1,127,880
Key Populations: MSM and TG $623,085
Training of health workers and community outreach workers
Collection and use of strategic information
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Key Populations: Sex Workers $444,795
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Gender: Gender Based Violence (GBV) $60,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building